NEW BRUNSWICK, N.J., April 17, 2012 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $16.1 billion for the first quarter of 2012, a decrease of 0.2% as

ZÜRICH, Switzerland and WEST CHESTER, Pennsylvania, March 20, 2012 /PRNewswire/ -- First Partnering Deal Based on Kuros' Synthetic Matrix Technologies

NEW BRUNSWICK, N.J., Jan.

NEW BRUNSWICK, N.J., Oct.

EXTON, Pa., Aug. 18, 2011 /PRNewswire/ -- Kensey Nash Corporation (NASDAQ: KNSY), a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its fourth quarter and fiscal year ended June 30, 2011.